Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-08-20

Clinical Trial Update: Combination Therapy With Imiquimod Cream 5% and Tazarotene Cream 0.1% for the Treatment of Lentigo Maligna [NA]

View source ↗

Summary

This completed clinical trial evaluated the combination of imiquimod 5% cream and tazarotene 0.1% cream for treating lentigo maligna, with results posted in 201…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Imiquimod Cream 5% (imiquimod)
  • Tazarotene cream 0.1% (Tazarotene)

Snippet

Sponsor: University of Utah | Conditions: Cancer, Lentigo Maligna | NA | Status: COMPLETED | Results posted: 2012-08-20